SLC7A5 and hepatocellular carcinoma: The mRNA expression levels of SLC7A5 and GLS were significantly decreased after treatment with JHU083, which demonstrated the successful inhibition of glutamine metabolism in subcutaneous hepatocellular carcinoma tumor tissue (Figure 6A,B).